"Dicing and Splicing" Sphingosine Kinase and Relevance to Cancer

被引:34
|
作者
Haddadi, Nahal [1 ]
Lin, Yiguang [1 ]
Simpson, Ann M. [1 ]
Nassif, Najah T. [1 ]
McGowan, Eileen M. [1 ]
机构
[1] Univ Technol Sydney, Sch Life Sci, Fac Sci, 15 Broadway, Sydney, NSW 2007, Australia
来源
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2017年 / 18卷 / 09期
关键词
sphingosine kinase (SphK); isozymes; variant isoforms; cancer therapy; sphingosine 1 phosphate (S1P); RESISTANT PROSTATE-CANCER; PROTEIN-COUPLED RECEPTOR; NEGATIVE BREAST-CANCER; LEUKEMIC HL-60 CELLS; LONG NONCODING RNA; IN-VIVO; OVARIAN-CANCER; FUNCTIONAL-CHARACTERIZATION; PROTEASOMAL DEGRADATION; ENDOTHELIAL-CELLS;
D O I
10.3390/ijms18091891
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Sphingosine kinase (SphK) is a lipid enzyme that maintains cellular lipid homeostasis. Two SphK isozymes, SphK1 and SphK2, are expressed from different chromosomes and several variant isoforms are expressed from each of the isozymes, allowing for the multi-faceted biological diversity of SphK activity. Historically, SphK1 is mainly associated with oncogenicity, however in reality, both SphK1 and SphK2 isozymes possess oncogenic properties and are recognized therapeutic targets. The absence of mutations of SphK in various cancer types has led to the theory that cancer cells develop a dependency on SphK signaling (hyper-SphK signaling) or non-oncogenic addiction. Here we discuss additional theories of SphK cellular mislocation and aberrant dicing and splicing as contributors to cancer cell biology and as key determinants of the success or failure of SphK/S1P (sphingosine 1 phosphate) based therapeutics.
引用
收藏
页数:25
相关论文
共 50 条
  • [1] Sphingosine kinase in cancer
    Pyne, Nigel J.
    Tonelli, Francesca
    Lim, Keng Gat
    Bittman, Robert
    Edwards, Joanne
    Watson, David G.
    Pyne, Susan
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2012, 30 : S8 - S8
  • [2] Splicing and dicing apoptosis genes
    Reed, JC
    NATURE BIOTECHNOLOGY, 1999, 17 (11) : 1064 - +
  • [3] The role of sphingosine kinase in cancer
    Pyne, Nigel J.
    Tonelli, Francesca
    Lim, Keng Gat
    Ossaimi, Manal
    Bittman, Robert
    Edwards, Joanne
    Watson, David G.
    Pyne, Susan
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2013, 32 : S34 - S34
  • [4] Sphingosine Kinase 1 in Cancer
    Heffernan-Stroud, Linda A.
    Obeid, Lina M.
    ROLE OF SPHINGOLIPIDS IN CANCER DEVELOPMENT AND THERAPY, 2013, 117 : 201 - 235
  • [5] Splicing and dicing with a SERRATEd edge
    Montgomery, Taiowa A.
    Carrington, James C.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (25) : 8489 - 8490
  • [6] Splicing and dicing apoptosis genes
    John C. Reed
    Nature Biotechnology, 1999, 17 : 1064 - 1065
  • [7] Sphingosine kinase as a "sensor" to chemotherapy in prostate cancer
    Pchejetski, D.
    Doumerc, N.
    Golzio, M.
    Calvet, C.
    Garcia, V.
    Rischmann, P.
    Tessie, J.
    Malavaud, B.
    Cuvillier, O.
    EJC SUPPLEMENTS, 2005, 3 (02): : 49 - 50
  • [8] Sphingosine kinase A promising cancer therapeutic target
    Antoon, James W.
    Beckman, Barbara S.
    CANCER BIOLOGY & THERAPY, 2011, 11 (07) : 647 - 650
  • [9] Sphingosine Kinase 1 and Sphingosine-1-Phosphate Signaling in Colorectal Cancer
    Bao, Yonghua
    Guo, Yongchen
    Zhang, Chenglan
    Fan, Fenghua
    Yang, Wancai
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (10)
  • [10] Downregulating sphingosine kinase-1 for cancer therapy
    Cuvillier, Olivier
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2008, 12 (08) : 1009 - 1020